Ling Yang
Tongji University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cancer-related molecular mechanisms research, Liver Disease Diagnosis and Treatment, RNA modifications and cancer, Genetic Associations and Epidemiology
Most-Cited Works
- → Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial(2015)838 cited
- → Natural selection on EPAS1 ( HIF2α ) associated with low hemoglobin concentration in Tibetan highlanders(2010)829 cited
- → Genomic Dissection of Population Substructure of Han Chinese and Its Implication in Association Studies(2009)342 cited
- → A Liver-Enriched Long Non-Coding RNA, lncLSTR, Regulates Systemic Lipid Metabolism in Mice(2015)278 cited
- → Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study(2022)163 cited
- → Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22(2010)160 cited
- → An inferred functional impact map of genetic variants in rice(2021)131 cited
- → Integrative Transcriptome Analyses of Metabolic Responses in Mice Define Pivotal LncRNA Metabolic Regulators(2016)127 cited
- → Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat(2010)101 cited
- → Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma(2016)86 cited